New Alzheimer’s drug: cause for hope or premature?
The United States Food and Drug Administration (FDA) has approved the first new drug developed for Alzheimer’s Disease in over 20 years...
As our understanding of the coronavirus develops, it has become clear that asymptomatic carriers could be the biggest threat.
As our understanding of the coronavirus develops, it has become clear that asymptomatic carriers could be the biggest threat.
As our understanding of the coronavirus develops, it has become clear that asymptomatic carriers could be the biggest threat.